These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 16266438

  • 21. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
    Cuenca-Estrella M, Rodriguez D, Almirante B, Morgan J, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Salvado M, Warnock DW, Pahissa A, Rodriguez-Tudela JL, Barcelona Candidemia Project Study Group.
    J Antimicrob Chemother; 2005 Feb; 55(2):194-9. PubMed ID: 15618284
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL, Cheng HH, Lo HJ.
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [Abstract] [Full Text] [Related]

  • 24. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS, Chang SC, Hsueh PR, Wang JL, Sun HY, Chen YC.
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [Abstract] [Full Text] [Related]

  • 25. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.
    Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, Hospitals T.
    Med Mycol; 2010 Mar; 48(2):328-34. PubMed ID: 20141372
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
    Fernández Andreu CM, Martínez Machin G, Illnait Zaragozi MT, Perurena Lancha MR, Aguila Sánchez A, Galloso Brito M.
    Rev Cubana Med Trop; 2007 Mar; 59(2):113-8. PubMed ID: 23427444
    [Abstract] [Full Text] [Related]

  • 28. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G, Sánchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hernández-Almaraz JL.
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
    Chen YC, Chang SC, Luh KT, Hsieh WC.
    J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
    [Abstract] [Full Text] [Related]

  • 31. [Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
    Porte L, León P, Gárate C, Guzmán AM, Labarca J, García P.
    Rev Chilena Infectol; 2012 Apr; 29(2):149-55. PubMed ID: 22689028
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 36. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [Abstract] [Full Text] [Related]

  • 37. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA, de Almeida LP, Machado AM, Azevedo AC, Kusano EJ, Travassos NF, Salomão R, Colombo AL.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [Abstract] [Full Text] [Related]

  • 38. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G.
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [Abstract] [Full Text] [Related]

  • 39. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006.
    Metwally L, Walker MJ, Coyle PV, Hay RJ, Hedderwick S, McCloskey BV, O'Neill HJ, Webb CH, McMullan R.
    J Infect; 2007 Aug; 55(2):174-8. PubMed ID: 17560655
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.